menu search

ACTG Announces Publication of REPRIEVE Trial in New England Journal of Medicine and Presentation at IAS 2023

ACTG Announces Publication of REPRIEVE Trial in New England Journal of Medicine and Presentation at IAS 2023
Data demonstrates that a daily statin can significantly lower risk of cardiovascular events among people living with HIV LOS ANGELES, July 23, 2023 (GLOBE NEWSWIRE) — The AIDS Clinical Trials Group (ACTG), a global clinical trials network focused on HIV, tuberculosis, hepatitis B and emerging infectious diseases, today announced the publication of “Pitavastatin to Prevent […] The post ACTG Announces Publication of REPRIEVE Trial in New England Journal of Medicine and Presentation at IAS 2023 app... Read More
Posted: Jul 23 2023, 23:45
Author Name: forextv
Views: 101857

Search within

Pages Search Results: